Skip to main content.

Valley Fever: Scientists took different routes to find vaccine

Valley Fever: The Search for an Effective Vaccine 

Fellowship Story Showcase

Valley Fever: Scientists took different routes to find vaccine

Scientists researching a vaccine for valley fever take different scientific approaches to their work. Some have been stymied by a lack of funding for their work.

Valley Fever: Scientists took different routes to find vaccine
Reporting on Health Collaborative
Sunday, October 7, 2012

Five scientists were chosen by a committee affiliated with California State University, Bakersfield, in 1997 to pursue valley fever vaccine research. To reach more about the search for a valley fever vaccine, click here.

Dr. John Galgiani, 66, professor at the University of Arizona and director of the Valley Fever Center for Excellence

  • Developed a vaccine that has been tested in mice and monkeys.
  • Currently working to improve the vaccine to make it cheaper to make.
  • Also working on Nikkomycin Z, a possible valley fever cure.

Dr. Demosthenes Pappagianis, 84, professor and director of the Coccidioidomycosis Serology Laboratoryat the University of California, Davis

  • Began studying the coccidioidesfungus in the early 1950s
  • Currently conducting vaccine tests on mice.
  • Trying to find the right formulation to generate a strong immune response.
  • Also studying how many doses of the vaccine have to be given, and precisely when, in order to get the maximum effect.

Dr. Garry Cole, 71, professor and chair in medical mycologyat the University of Texas at San Antonio

  • Generated a live vaccine that has been tested in mice.
  • Vaccine has been attenuated – meaning weakened – to make it safe for immunizations.
  • Working to modify vaccine to confirm that – once injected – it would not become infectious.
  • Hoping to test the vaccine in primates and, eventually, humans.
  • Developing a second vaccine with a different formulation.

Dr. Rebecca Cox, 62, scientist at the University of Texas Health Science Center at San Antonio.

  • Studied the coccidioidesfungus for 30 years.
  • Focused on the role of the human immune system in combating the fungus once it was inhaled.
  • Died July 14, 2006.

Dr. Theo Kirkland, 62, professor of pathology and medicine at the University of California, San Diego.

  • Tested a vaccine in mice but wasn’t able to pursue it further.
  • Stopped doing research on valley fever after funding for his project ran out.

Related Stories:

Valley Fever Vaccine Stalls

Just One Breath: Valley fever cases reach epidemic levels, but harm remains hidden 

Valley Fever Costs Mount for Patients and Taxpayers

Taxpayers spend millions on valley fever in prisons

Just One Breath: Five Tips for Writing about Health Costs

About This Series

This project results from an innovative reporting venture – the Center for Health Journalism Collaborative – which currently involves the Bakersfield Californian, Radio Bilingüe in Fresno, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, Hanford Sentinel, the Voice of OC in Santa Ana, the Arizona Daily Star in Tucson, La Estrella de Tucsón and the Center for Health Journalism. The collaborative is an initiative of the Center for Health Journalism at the University of Southern California’s Annenberg School for Communication and Journalism.


A Fever in the Dust

Although still unknown outside of the American west, valley fever is a severe fungal infection — and its territory may expand as the climate warms.

In 2018, Governor Jerry Brown Allocated $8 million to Cocci Research And Awareness. How Has It Been Spent?

In his final 2018-2019 budget former California Gov. Jerry Brown allocated $8 million in state funding toward combating valley fever, split evenly between the University of California system and the new Valley Fever Institute at Kern Medical in Bakersfield. Here’s how that money’s been spent.

Following Funding Boosts, Momentum Builds Around Valley Fever Research

Researchers have been trying to understand valley fever for decades, but the playing field remained small until recently.

‘Eureka moment’ in valley fever case paves way for new research, treatment options

UCLA's Dr. Manish Butte still remembers the day almost two years ago when he met a young boy who could barely walk or talk and needed a feeding tube to eat. He was suffering from a life-threatening case of valley fever.

Valley fever medication poses added risk for pregnant women

Research suggests an alarming link between a common drug used for valley fever and birth defects. The disease also tends to be more severe in pregnant women.

Legislation caps momentous year in battle against valley fever

Recently signed legislation capped a big year for efforts to combat a regional disease long overlooked by lawmakers.

For valley fever survivors, a growing need: wigs

The antifungal drugs used to treat valley fever can cause hair loss. With the number of valley fever cases on the rise, a wig shop in Bakersfield, Calif., is helping women feel better about themselves.

California budget boosts funding for valley fever

The budget includes $8 million for research and outreach into the disease, caused by inhaling spores that grow in arid soil.